FDA Adverse Event Injury Summary report: N

I-GEL RESUS PACK 4

MDR report key: 19373610 · Received May 21, 2024

Report

Report Number
MW5155214
Event Type
Injury
Date Received
May 21, 2024
Date of Event
May 19, 2024
Report Date
May 19, 2024
Manufacturer
INTERSURGICAL, INC.
Product Code
CAE
Adverse Event
Yes
Report Source
Voluntary report
Reporter Location
MO, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Description of Event or Problem · 0

PATIENT BEGAN SUFFERING UPPER AIRWAY BLEEDING DURING A CARDIAC ARREST RESUSCITATION FOLLOWING PLACEMENT AND USE OF AN IGEL SUPRAGLOTTIC AIRWAY. AN EXPERIENCED PROVIDER (17 YEARS AS A PARAMEDIC) WITH HUNDREDS OF OUT OF HOSPITAL CARDIAC ARRESTS ATTENDED AND HUNDREDS OF IGEL PLACEMENTS INSERTED A NUMBER 4 IGEL, PLACED VIA MANUFACTURER INSTRUCTION, LUBRICATED WITH SUPPLIED WATER-BASED LUBRICANT, SECURED WITH SUPPLIED ELASTIC GREEN STRAP. A BAG MASK WAS ATTACHED TO THE PATIENT AND VENTILATION GIVEN DURING RESUSCITATION WITH CARDIOPULMONARY RESUSCITATION DURING THE 30 MINUTES AND MULTIPLE DEFIBRILLATION ATTEMPTS. BRIGHT RED BLOOD BEGAN FILLING THE IGEL AFTER APPROXIMATELY 28 MINUTES INTO THE RESUSCITATION, AND THIS INCREASED IN VOLUME DURING TRANSPORT UNTIL IGEL WAS REMOVED AT HOSPITAL AND REPLACED WITH ENDOTRACHEAL TUBE. TOTAL TIME OF PREHOSPITAL CARE APPROXIMATELY 45 MINUTES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2305040 I-GEL RESUS PACK 4 AIRWAY, OROPHARYNGEAL, ANESTHESIOLOGY CAE INTERSURGICAL, INC.

Patients

Seq Age Sex Outcome Treatment
1 NA Female Other ALBUTEROL.| ASPIRIN. | ATORVASTATIN.| CARVEDILOL.| FLUOXETINE.| INSULIN.| LASIX.